What happens when you drink rooibos tea and what does it do to liver enzymes?
Rooibos (Aspalathus linearis) is a needle-leafed shrub native to the western Cape of South Africa. The leaves are fermented and dried to make the familiar red bush tea, which is naturally caffeine-free and has a mild, slightly sweet flavor. Unfermented "green" rooibos retains more of its native polyphenols.
The principal bioactive compounds in rooibos are aspalathin (a unique dihydrochalcone), nothofagin, orientin, isoorientin, vitexin, isovitexin, and rutin. These polyphenols have antioxidant activity in laboratory assays and have been investigated for blood sugar, blood pressure, and cardiovascular effects. Population-level consumption data and many clinical studies suggest rooibos is well tolerated.
However, two published case reports raise a note of caution about the liver. In 2010, Sinisalo and colleagues described a 42-year-old patient with Waldenstrom's macroglobulinemia (a lymphoma-related condition) who developed transiently elevated liver enzymes after consuming a large daily volume of rooibos tea; enzymes normalized when the tea was stopped and rose again on rechallenge. A separate case report by Engels and colleagues in 2013 described a 52-year-old man who developed acute hepatitis after several months of drinking rooibos tea, with biopsy findings consistent with toxin-mediated liver injury, and recovery after discontinuation.
Beyond these case reports, rooibos has been shown in laboratory work to modulate hepatic cytochrome P450 (CYP) enzymes, including CYP1A2, CYP2C9, CYP2C19, and CYP3A4. The clinical importance in human drug metabolism is uncertain, but it raises a theoretical possibility that heavy rooibos consumption could alter blood levels of medications metabolized by these enzymes.
Why is this important?
The good news is that the absolute risk of liver injury from rooibos in the general population appears very low. Millions of people drink rooibos daily without measurable liver problems, and most clinical studies in healthy volunteers do not show liver enzyme elevations.
The cases that have been reported share several features that may identify higher-risk users: heavy daily consumption (multiple liters or many cups), an underlying medical condition affecting the liver or immune system, and concurrent medications. The CYP-modulating activity is most likely to matter in patients who take medications with a narrow therapeutic window (warfarin, digoxin, tacrolimus, cyclosporine, certain antiepileptics, certain antipsychotics) and who consume large daily amounts of rooibos.
The interaction concern is also relevant in pregnancy if rooibos is combined with high doses of other herbs in commercial "detox" or "liver cleanse" blends, where the combined herbal load is much greater than what most users assume.
What should you do?
For healthy adults, drinking one to three cups of rooibos tea daily is generally safe and does not require any special monitoring of liver enzymes.
If you have a known liver condition (hepatitis B or C, fatty liver disease, autoimmune hepatitis, cirrhosis), are taking medications with potential liver toxicity (methotrexate, isoniazid, valproate, amiodarone, statins, acetaminophen at the higher end of dosing, many cancer chemotherapies), or are at higher baseline risk, talk to your clinician before making rooibos a daily habit and consider periodic liver function tests if you drink large quantities.
If you are on a medication with a narrow therapeutic window that depends on CYP metabolism (warfarin, tacrolimus, cyclosporine, digoxin, clozapine), do not consume large daily amounts of rooibos without telling your prescriber, and keep your intake steady rather than fluctuating.
Watch for early signs of liver injury: persistent fatigue, loss of appetite, nausea or vomiting, right upper abdominal discomfort, yellowing of the skin or eyes (jaundice), dark urine, or pale stools. Any of these warrant prompt evaluation, including a liver enzyme panel (AST, ALT, alkaline phosphatase, bilirubin) and discontinuation of all non-essential herbal products.
Be especially cautious with combination herbal teas marketed as "detox," "liver cleanse," or "slimming" products, even when rooibos is the named base. Many of these blends contain additional herbs with documented hepatotoxicity (such as green tea extract in concentrated form, kava, comfrey, chaparral, germander, kratom, or certain Chinese formulas).
Which specific products are affected?
The concern applies to rooibos preparations: fermented red rooibos tea bags and loose tea, green (unfermented) rooibos, rooibos espresso and lattes, rooibos extracts and capsules sold for cardiovascular or anti-aging support, and herbal blends that use rooibos as a base.
On the medication side, the theoretical interaction risk is greatest for drugs metabolized by CYP1A2, CYP2C9, CYP2C19, and CYP3A4 with narrow therapeutic windows. Examples include warfarin, tacrolimus, cyclosporine, sirolimus, digoxin, clozapine, theophylline, phenytoin, carbamazepine, valproate, and many oncology drugs. Existing hepatotoxic medications (methotrexate, isoniazid, amiodarone, ketoconazole, statins) may stack with any rooibos-related hepatic effect.
The bottom line
Rooibos tea is generally safe for the liver in healthy adults at usual intakes of one to three cups per day. Rare case reports describe transient liver enzyme elevations or acute hepatitis with heavy consumption, and laboratory work shows rooibos can modulate hepatic CYP enzymes that metabolize many drugs. If you have liver disease, take hepatotoxic medications, take drugs with a narrow therapeutic window, or notice new fatigue, jaundice, or abdominal discomfort, stop rooibos and ask your clinician for a liver function panel. Otherwise, enjoy your tea in moderation.